Judges Scientific plc (the "Company")
9 February 2015
Director/PDMR Shareholding
Judges Scientific has today been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 5 February 2015 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:
A total of nine Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,540 Ordinary Shares representing 15.28 per cent of the issued Ordinary share capital. In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.
A total of nine Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company. His resulting interest in the Company is 58,059 Ordinary Shares representing 0.97 per cent of the issued Ordinary share capital. In addition, he holds options over 7,875 Ordinary Shares under the Company's Share Option Plans.
The purchases by the Trustees were made at a price of 1665.00p per Ordinary Share. Purchases of a further 410 Ordinary Shares were made on the same date and at the same price on behalf of 60 other members of staff under the Plan.
For further information please contact:
Judges Scientific plc
David Cicurel, CEO
Tel: 01342 323 600
Shore Capital (Nominated Adviser & Broker)
Pascal Keane
Edward Mansfield
Tel: 020 7408 4090
Cardew Group (Financial Public Relations)
Melvyn Marckus
Tel: 020 7930 0777 or 07775 896 491
Website:
Judges Scientific: www.judges.uk.com